P-224 XPD polymorphisms in cisplatin (cis)/vinorelbine (vrb)-treated stage IV non-small-cell lung cancer (NSCLC) patients (p): genetic analysis of a Spanish Lung Cancer Group phase II trial

Autor:	Vicente Alberola, Mariano Provencio, Manuel Cobo, Noemi Reguart, Barbara Roig, Felipe Cardenal, Mireja Margeli, Nuria Vin˜olas, Francisco Javier Baron-Duarte, Rafael Rosell
Rok vydání:	2003
Předmět:	Pulmonary and Respiratory Medicine Cisplatin Oncology Cancer Research medicine.medical_specialty business.industry Vinorelbine medicine.disease Genetic analysis Stage IV non-small cell lung cancer Internal medicine medicine business Lung cancer medicine.drug
Zdroj:	Lung Cancer. 41:S148
ISSN:	0169-5002
DOI:	10.1016/s0169-5002(03)92193-3
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::261295db858817298805bbd477bb6871 https://doi.org/10.1016/s0169-5002(03)92193-3 Zobrazit plný text záznamu Full Text from ScienceDirect